BioLamina AB - Company Review
BioLamina AB - Company ReviewSummary
BioLamina AB (BioLamina) is a biotechnology company that focuses on the development, manufacture and distribution of cell culture reagents intended for culturing primary cells. The company offers a wide portfolio of chemically defined and xeno-free laminin proteins. Its product portfolio includes Laminin-521, a recombinant human protein, which is the natural laminin for pluripotent stem cells; Laminin-111, for early epithelial development and differentiation of the epiblast; and LAMscreen that enables the screening of the best laminins for different cell types. BioLamina’s products find application in maintaining endothelial cells, eye applications, hepatic, kidney cell culture, neural, pancreatic and skeletal muscle applications. The company operates through its distribution partners in Asia, Europe and the Americas, among others. BioLamina is headquartered in Stockholm, Sweden.
This comprehensive company report of BioLamina AB provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.